Scolaris Content Display Scolaris Content Display

Study flow diagram.
Figuras y tablas -
Figure 1

Study flow diagram.

'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
Figuras y tablas -
Figure 2

'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.
Figuras y tablas -
Figure 3

'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.

Comparison 1 Integrated CBT vs Twelve Step Facilitation, Outcome: Depression at 6‐12 months
Figuras y tablas -
Figure 4

Comparison 1 Integrated CBT vs Twelve Step Facilitation, Outcome: Depression at 6‐12 months

Comparison 1 Integrated CBT vs Twelve Step Facilitation, Outcome: Percentage of Days Abstinent at 6 to 12 months.
Figuras y tablas -
Figure 5

Comparison 1 Integrated CBT vs Twelve Step Facilitation, Outcome: Percentage of Days Abstinent at 6 to 12 months.

Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome: Depression at end of treatment.
Figuras y tablas -
Figure 6

Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome: Depression at end of treatment.

Comparison 1 Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment, Outcome 1 Depression ‐ HDRS: end of treatment.
Figuras y tablas -
Analysis 1.1

Comparison 1 Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment, Outcome 1 Depression ‐ HDRS: end of treatment.

Comparison 1 Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment, Outcome 2 Depression ‐ HDRS: 6‐ to 12‐month follow‐up.
Figuras y tablas -
Analysis 1.2

Comparison 1 Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment, Outcome 2 Depression ‐ HDRS: 6‐ to 12‐month follow‐up.

Comparison 1 Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment, Outcome 3 Substance use ‐ PDA: end of treatment.
Figuras y tablas -
Analysis 1.3

Comparison 1 Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment, Outcome 3 Substance use ‐ PDA: end of treatment.

Comparison 1 Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment, Outcome 4 Substance use ‐ PDA: 6‐ to 12‐month follow‐up.
Figuras y tablas -
Analysis 1.4

Comparison 1 Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment, Outcome 4 Substance use ‐ PDA: 6‐ to 12‐month follow‐up.

Comparison 1 Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment, Outcome 5 Treatment retention.
Figuras y tablas -
Analysis 1.5

Comparison 1 Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment, Outcome 5 Treatment retention.

Comparison 1 Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment, Outcome 6 Treatment attendance.
Figuras y tablas -
Analysis 1.6

Comparison 1 Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment, Outcome 6 Treatment attendance.

Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome 1 Depression ‐ HDRS: end of treatment.
Figuras y tablas -
Analysis 2.1

Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome 1 Depression ‐ HDRS: end of treatment.

Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome 2 Depression ‐ HDRS ‐ 3‐month follow‐up (IPT‐D vs Psychoed).
Figuras y tablas -
Analysis 2.2

Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome 2 Depression ‐ HDRS ‐ 3‐month follow‐up (IPT‐D vs Psychoed).

Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome 3 Substance use ‐ PDA: end of treatment (IPT vs BST).
Figuras y tablas -
Analysis 2.3

Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome 3 Substance use ‐ PDA: end of treatment (IPT vs BST).

Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome 4 Substance use ‐ Relapse: 3‐month follow‐up (IPT vs Psychoed).
Figuras y tablas -
Analysis 2.4

Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome 4 Substance use ‐ Relapse: 3‐month follow‐up (IPT vs Psychoed).

Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome 5 Treatment retention.
Figuras y tablas -
Analysis 2.5

Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome 5 Treatment retention.

Comparison 3 Combined FFT & CWD vs sequential FFT‐CWD; Combined FFT & CSD vs sequential CWD‐FFT, Outcome 1 Depression ‐ CDRS‐R: end of treatment.
Figuras y tablas -
Analysis 3.1

Comparison 3 Combined FFT & CWD vs sequential FFT‐CWD; Combined FFT & CSD vs sequential CWD‐FFT, Outcome 1 Depression ‐ CDRS‐R: end of treatment.

Comparison 3 Combined FFT & CWD vs sequential FFT‐CWD; Combined FFT & CSD vs sequential CWD‐FFT, Outcome 2 Depression ‐ CDRS‐R: 12‐month follow‐up.
Figuras y tablas -
Analysis 3.2

Comparison 3 Combined FFT & CWD vs sequential FFT‐CWD; Combined FFT & CSD vs sequential CWD‐FFT, Outcome 2 Depression ‐ CDRS‐R: 12‐month follow‐up.

Comparison 3 Combined FFT & CWD vs sequential FFT‐CWD; Combined FFT & CSD vs sequential CWD‐FFT, Outcome 3 Substance use ‐ square root % daily use: end of treatment.
Figuras y tablas -
Analysis 3.3

Comparison 3 Combined FFT & CWD vs sequential FFT‐CWD; Combined FFT & CSD vs sequential CWD‐FFT, Outcome 3 Substance use ‐ square root % daily use: end of treatment.

Comparison 3 Combined FFT & CWD vs sequential FFT‐CWD; Combined FFT & CSD vs sequential CWD‐FFT, Outcome 4 Substance use ‐ square root % daily use: 12‐month follow‐up.
Figuras y tablas -
Analysis 3.4

Comparison 3 Combined FFT & CWD vs sequential FFT‐CWD; Combined FFT & CSD vs sequential CWD‐FFT, Outcome 4 Substance use ‐ square root % daily use: 12‐month follow‐up.

Comparison 3 Combined FFT & CWD vs sequential FFT‐CWD; Combined FFT & CSD vs sequential CWD‐FFT, Outcome 5 Premature termination.
Figuras y tablas -
Analysis 3.5

Comparison 3 Combined FFT & CWD vs sequential FFT‐CWD; Combined FFT & CSD vs sequential CWD‐FFT, Outcome 5 Premature termination.

Comparison 3 Combined FFT & CWD vs sequential FFT‐CWD; Combined FFT & CSD vs sequential CWD‐FFT, Outcome 6 Treatment attendance.
Figuras y tablas -
Analysis 3.6

Comparison 3 Combined FFT & CWD vs sequential FFT‐CWD; Combined FFT & CSD vs sequential CWD‐FFT, Outcome 6 Treatment attendance.

Comparison 4 Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention, Outcome 1 Depression ‐ HDRS: end of treatment.
Figuras y tablas -
Analysis 4.1

Comparison 4 Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention, Outcome 1 Depression ‐ HDRS: end of treatment.

Comparison 4 Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention, Outcome 2 Depression ‐ BDI‐II: end of treatment.
Figuras y tablas -
Analysis 4.2

Comparison 4 Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention, Outcome 2 Depression ‐ BDI‐II: end of treatment.

Comparison 4 Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention, Outcome 3 Substance use ‐ Opiates: end of treatment.
Figuras y tablas -
Analysis 4.3

Comparison 4 Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention, Outcome 3 Substance use ‐ Opiates: end of treatment.

Comparison 4 Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention, Outcome 4 Substance use ‐ Cocaine: end of treatment.
Figuras y tablas -
Analysis 4.4

Comparison 4 Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention, Outcome 4 Substance use ‐ Cocaine: end of treatment.

Comparison 4 Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention, Outcome 5 Substance use ‐ Benzodiazepines: end of treatment.
Figuras y tablas -
Analysis 4.5

Comparison 4 Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention, Outcome 5 Substance use ‐ Benzodiazepines: end of treatment.

Comparison 4 Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention, Outcome 6 Treatment attendance.
Figuras y tablas -
Analysis 4.6

Comparison 4 Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention, Outcome 6 Treatment attendance.

Summary of findings for the main comparison. Integrated CBT compared with Twelve Step Facilitation for co‐occurring depression and substance use disorders

Integrated CBT compared with Twelve Step Facilitation for co‐occurring depression and substance use disorders

Patient or population: co‐occurring depression and substance use disorders
Setting:
Intervention: Integrated CBT
Comparison: Twelve Step Facilitation

Outcomes

Anticipated absolute effects* (95% CI)

Relative effect
(95% CI)

№ of participants
(studies)

Certainty of the evidence
(GRADE)

Comments

Risk with Twelve Step Facilitation

Risk with Integrated CBT

Depression score
Assessed with: Hamilton Depression Rating Scale (HDRS) ‐ Structured clinical interview (21 items)
Scale from: 0 to 54 (higher score worse)
Follow‐up: end of treatment

The mean depression score ranged from 21.0 to 23.2

MD 4.05 higher
(1.43 higher to 6.66 higher)

212
(2 RCTs)

⊕⊝⊝⊝
VERY LOW 1 2 3

Depression score
Assessed with: Hamilton Depression Rating Scale (HDRS) ‐ Structured clinical interview (21 items)
Scale from: 0 to 54 (higher score worse)
Follow‐up: 6 months to 12 months

The mean depression score ranged from 21.0 to 27.9

MD 1.53 higher
(1.73 lower to 4.79 higher)

181
(2 RCTs)

⊕⊝⊝⊝
VERY LOW 1 2 3

Percent of days abstinent
Assessed with: The calendar‐assisted structured interview ‐ Time‐Line Follow‐Back (TLFB) for past 3‐month substance use
Scale from: 0 to 100 (lower score better)
Follow‐up: end of treatment

The mean proportion of days abstinent ranged from 93 to 90

MD 2.84 lower
(8.04 lower to 2.35 higher)

220
(2 RCTs)

⊕⊝⊝⊝
VERY LOW 1 2 3

Percent of days abstinent
Assessed with: TLFB for past 3‐month substance use
Scale from: 0 to 100 (lower score better)
Follow‐up: 6 months to 12 months

The mean proportion of days abstinent ranged from 72 to 75

MD 10.76 higher
(3.10 higher to 18.42 higher)

189
(2 RCTs)

⊕⊝⊝⊝
VERY LOW 2 3 4

Treatment retention
Assessed with: dropped out of treatment after attending an average of 1.2 sessions

Moderate

RR 0.95
(0.72 to 1.25)

296
(2 RCTs)

⊕⊝⊝⊝
VERY LOW 1 2 3

785 per 1,000

745 per 1,000
(565 to 981)

Number of treatment sessions attended
Scale from: 0 to 36

The mean number of Treatment Sessions Attended ranged from 19.4‐22.1

MD 1.27 lower
(6.10 lower to 3.56 higher)

270
(2 RCTs)

⊕⊝⊝⊝
VERY LOW 2 3 5

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

CI: Confidence interval; MD: mean difference; RR: Risk ratio

GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: we are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low certainty: our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of the effect
Very low certainty: we have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect

1 Downgraded two levels due to very serious risk of bias: high levels of performance bias, attrition bias and uneven medication use between groups. One study also had high risk of selection bias and unclear risk for selective reporting.

2 Downgraded one level due to Imprecision: small number of trials/participants

3 Downgraded one level due to indirectness: population of predominately Caucasian male veterans

4 Downgraded two levels due to very serious risk of bias: high levels of selection bias, performance bias, attrition bias, unclear risk for selective reporting and uneven attendance between groups at 12‐step Community Meetings

5 Downgraded two levels due to very serious risk of bias: mean attendance was based on a reduced sample, not those originally randomised into the study. Also high risk of selection bias, performance bias and attrition bias

Figuras y tablas -
Summary of findings for the main comparison. Integrated CBT compared with Twelve Step Facilitation for co‐occurring depression and substance use disorders
Summary of findings 2. Interpersonal Psychotherapy for Depression (IPT‐D) compared with Other Psychological Interventions for co‐occurring depression and substance use disorders

Interpersonal Psychotherapy for Depression (IPT‐D) compared with Other Psychological Interventions for co‐occurring depression and substance use disorders

Patient or population: Individuals experiencing co‐occurring depression and substance use disorders
Setting: any setting
Intervention: Interpersonal Psychotherapy for Depression (IPT‐D)
Comparison: Other Psychological Interventions

Outcomes

Anticipated absolute effects* (95% CI)

Relative effect
(95% CI)

№ of participants
(studies)

Certainty of the evidence
(GRADE)

Comments

Risk with Other Theraputic Interventions

Risk with Interpersonal Psychotherapy for Depression (IPT‐D)

Depression score
Assessed with: Hamilton Depression Rating Scale (HDRS) ‐ Structured clinical interview (17 and 24 items)
Scale from: 0 to 54 (higher score worse)
Follow‐up: end of treatment

SMD 0.54 SD lower
(1.04 lower to 0.04 lower)

64
(2 RCTs)

⊕⊝⊝⊝
VERY LOW 1 2 3

Depression score
Assessed with: Hamilton Depression Rating Scale (HDRS) ‐ Structured clinical interview (17 items)
Scale from: 0 to 54 (higher score worse)
Follow‐up: 3 months

The mean depression score was 15.8

MD 3.80 higher
(3.83 lower to 11.43 higher)

38
(1 RCT)

⊕⊝⊝⊝
VERY LOW 3 4 5

Percentage of days abstinent
Assessed with: the calendar‐assisted structured interview ‐ Time‐Line Follow‐Back (TLFB) for past month of alcohol use
Scale from: 0 to 100 (better)
Follow‐up: end of treatment

The mean percentage of days abstinent was 49.7

MD 2.70 lower
(28.74 lower to 23.34 higher)

26
(1 RCT)

⊕⊝⊝⊝
VERY LOW 3 6 7

Substance use ‐ relapse
Assessed with: self‐reported heavy drinking (4+ drinks) or drug use on at least 10% of non‐incarcerated days or positive urine test
Follow‐up: 3‐months

Study population

RR 0.67
(0.30 to 1.50)

38
(1 RCT)

⊕⊝⊝⊝
VERY LOW 3 4 5

316 per 1,000

212 per 1,000
(95 to 474)

Treatment retention

Study population

RR 1.00
(0.81 to 1.23)

64
(2 RCTs)

⊕⊝⊝⊝
VERY LOW 1 2 3

774 per 1,000

744 per 1,000
(627 to 952)

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

CI: Confidence interval; MD: mean difference; RR: Risk ratio; SMD: standardised mean difference

GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: we are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low certainty: our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of the effect
Very low certainty: we have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect

1 Downgraded two levels due to serious risk of bias: high levels of performance bias due to difficulties with blinding participants and personnel, one of the studies also had high attrition bias and reported group differences in use of antidepressants and adjunctive mental health counselling

2 Downgraded one level due to indirectness: one of the study was based on a female prison population, the other were recruited through a medical college, neither sample is likely to be representative of broader population of individuals experience comorbid substance use and depressive disorders

3 Downgraded two levels due to very small sample size

4 Downgraded two levels due to serious risk of bias: high levels of performance bias due to difficulties with blinding participants and personnel and reported group differences in use of antidepressants and adjunctive mental health counselling

5 Downgraded one level due to indirectness: Female prison population unlikely to be representative of broader population of individuals experience comorbid substance use and depressive disorders

6 Downgraded two levels due to serious risk of bias: high levels of performance bias due to difficulties with blinding participants and personnel

7 Downgraded one level due to indirectness: sample recruited through a medical college, predominately White male, unlikely to be representative of broader population of individuals experience comorbid substance use and depressive disorders

Figuras y tablas -
Summary of findings 2. Interpersonal Psychotherapy for Depression (IPT‐D) compared with Other Psychological Interventions for co‐occurring depression and substance use disorders
Comparison 1. Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Depression ‐ HDRS: end of treatment Show forest plot

2

212

Mean Difference (IV, Random, 95% CI)

4.05 [1.43, 6.66]

2 Depression ‐ HDRS: 6‐ to 12‐month follow‐up Show forest plot

2

181

Mean Difference (IV, Random, 95% CI)

1.53 [‐1.73, 4.79]

3 Substance use ‐ PDA: end of treatment Show forest plot

2

220

Mean Difference (IV, Random, 95% CI)

‐2.84 [‐8.04, 2.35]

4 Substance use ‐ PDA: 6‐ to 12‐month follow‐up Show forest plot

2

189

Mean Difference (IV, Random, 95% CI)

10.76 [3.10, 18.42]

5 Treatment retention Show forest plot

2

296

Risk Ratio (M‐H, Random, 95% CI)

0.95 [0.72, 1.25]

6 Treatment attendance Show forest plot

2

270

Mean Difference (IV, Random, 95% CI)

‐1.27 [‐6.10, 3.56]

Figuras y tablas -
Comparison 1. Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment
Comparison 2. Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Depression ‐ HDRS: end of treatment Show forest plot

2

64

Std. Mean Difference (IV, Random, 95% CI)

‐0.54 [‐1.04, ‐0.04]

2 Depression ‐ HDRS ‐ 3‐month follow‐up (IPT‐D vs Psychoed) Show forest plot

1

Mean Difference (IV, Random, 95% CI)

Subtotals only

3 Substance use ‐ PDA: end of treatment (IPT vs BST) Show forest plot

1

Mean Difference (IV, Random, 95% CI)

Subtotals only

4 Substance use ‐ Relapse: 3‐month follow‐up (IPT vs Psychoed) Show forest plot

1

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

5 Treatment retention Show forest plot

2

64

Risk Ratio (M‐H, Random, 95% CI)

1.00 [0.81, 1.23]

Figuras y tablas -
Comparison 2. Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions
Comparison 3. Combined FFT & CWD vs sequential FFT‐CWD; Combined FFT & CSD vs sequential CWD‐FFT

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Depression ‐ CDRS‐R: end of treatment Show forest plot

1

Mean Difference (IV, Random, 95% CI)

Subtotals only

2 Depression ‐ CDRS‐R: 12‐month follow‐up Show forest plot

1

Mean Difference (IV, Random, 95% CI)

Subtotals only

3 Substance use ‐ square root % daily use: end of treatment Show forest plot

1

Mean Difference (IV, Random, 95% CI)

Subtotals only

4 Substance use ‐ square root % daily use: 12‐month follow‐up Show forest plot

1

Mean Difference (IV, Random, 95% CI)

Subtotals only

5 Premature termination Show forest plot

1

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

6 Treatment attendance Show forest plot

1

Mean Difference (IV, Random, 95% CI)

Subtotals only

Figuras y tablas -
Comparison 3. Combined FFT & CWD vs sequential FFT‐CWD; Combined FFT & CSD vs sequential CWD‐FFT
Comparison 4. Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Depression ‐ HDRS: end of treatment Show forest plot

1

24

Mean Difference (IV, Random, 95% CI)

2.10 [‐6.03, 10.23]

2 Depression ‐ BDI‐II: end of treatment Show forest plot

1

24

Mean Difference (IV, Random, 95% CI)

6.60 [‐4.94, 18.14]

3 Substance use ‐ Opiates: end of treatment Show forest plot

1

24

Mean Difference (IV, Random, 95% CI)

0.11 [‐0.09, 0.31]

4 Substance use ‐ Cocaine: end of treatment Show forest plot

1

24

Mean Difference (IV, Random, 95% CI)

0.1 [‐0.13, 0.33]

5 Substance use ‐ Benzodiazepines: end of treatment Show forest plot

1

24

Mean Difference (IV, Random, 95% CI)

0.02 [‐0.21, 0.25]

6 Treatment attendance Show forest plot

1

38

Mean Difference (IV, Random, 95% CI)

‐3.70 [‐7.83, 0.43]

Figuras y tablas -
Comparison 4. Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention